Technical Analysis for OPGN - OpGen, Inc.

Grade Last Price % Change Price Change
grade F 0.5 13.10% 0.06
OPGN closed up 13.1 percent on Monday, May 20, 2019, on 48 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Very Strong Down Down Up
See historical OPGN trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Wide Bands Range Expansion 0.00%
Up 3 Days in a Row Strength 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Lower Bollinger Band Walk Weakness 13.10%
Wide Bands Range Expansion 13.10%
Lower Bollinger Band Touch Weakness 13.10%
Lower Bollinger Band Walk Weakness 19.05%
Inside Day Range Contraction 19.05%
Wide Bands Range Expansion 19.05%

Older signals for OPGN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
OpGen, Inc. operates as an early commercial stage company using molecular testing and bioinformatics to assist healthcare providers to combat multi-drug-resistant bacterial infections. It offers Acuitas multi-drug-resistant organisms (MDRO) gene test, a molecular screening tool that detects 10 critical MDRO genes from 1 patient swab. The company also provides Acuitas CR Elite Test, which adds the ability to procure a standard microbiological culture result that provides additional information about the identified MDRO gene and its antibiotic susceptibility profile. In addition, it develops Acuitas Lighthouse MDRO bioinformatics product, which focuses on providing MDRO molecular information about an individual patient's resistance profile. OpGen, Inc. has a strategic collaboration with Hitachi High-Technologies Corporation to commercialize its genome mapping technology for mapping, assembly, and analysis of human DNA. The company was incorporated in 2001 and is headquartered in Gaithersburg, Maryland.
Health Healthcare Providers Pharmaceuticals Policy Antibiotic Antimicrobial Resistance Bacteria Veterinary Medicine Bioinformatics Evolutionary Biology Multi Drug Resistant Bacterial Infections
Is OPGN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 2.9
52 Week Low 0.36
Average Volume 363,149
200-Day Moving Average 1.3198
50-Day Moving Average 0.6633
20-Day Moving Average 0.4915
10-Day Moving Average 0.4726
Average True Range 0.0539
ADX 61.75
+DI 11.81
-DI 31.5685
Chandelier Exit (Long, 3 ATRs ) 0.4183
Chandelier Exit (Short, 3 ATRs ) 0.5217
Upper Bollinger Band 0.5675
Lower Bollinger Band 0.4155
Percent B (%b) 0.56
BandWidth 30.925738
MACD Line -0.0588
MACD Signal Line -0.0707
MACD Histogram 0.0119
Fundamentals Value
Market Cap 25.78 Million
Num Shares 51.6 Million
EPS -0.77
Price-to-Earnings (P/E) Ratio -0.65
Price-to-Sales 5.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.64
Resistance 3 (R3) 0.62 0.56 0.61
Resistance 2 (R2) 0.56 0.53 0.57 0.60
Resistance 1 (R1) 0.53 0.50 0.55 0.55 0.60
Pivot Point 0.47 0.47 0.48 0.48 0.47
Support 1 (S1) 0.44 0.44 0.46 0.46 0.40
Support 2 (S2) 0.38 0.41 0.39 0.40
Support 3 (S3) 0.35 0.38 0.39
Support 4 (S4) 0.37